Literature DB >> 25364036

Paraneoplastic Neurological Syndrome in Fallopian Tube Cancer.

E Maas1, T Skoberne2, A Werner1, S Braun3, C Jackisch1.   

Abstract

We report on a rare case of paraneoplastic syndrome (PS) that was discovered on completion of diagnostic work-up to be an undifferentiated fallopian tube carcinoma. A 49-year-old Caucasian woman was admitted to neurology with vertigo, gait ataxia and dysarthria, transient ischaemic attack (TIA) and stroke were quickly excluded. Indicative for the further diagnosis of a paraneoplastic syndrome was the identification of onconeuronal antibodies the detection of which can be associated with certain tumour entities. The strongly positive anti-Yo antibody that is formed above all by breast and lung cancers as well as ovarian cancer led to a corresponding staging. The tumour markers CEA, CA 125 and CA 15-3 were in the normal ranges. Mammography and thorax CT were also unremarkable; on transvaginal sonography the internal genitals were inconspicuous except for a follicular cyst on the left. On abdominal CT the only conspicuous finding was a 1.5 cm ovarian cyst. After consensual agreement a bilateral laparoscopic adenexectomy was performed but with unremarkable abdominal findings. The histological examination confirmed a right-sided undifferentiated tubal carcinoma with the provisional classification FIGO IIA. After a stage-related staging operation, the final classification was found to be the FIGO-IIIC stage on account of positive retroperitoneal lymph nodes. Thus adjuvant chemotherapy with 6 cycles of carboplatin and paclitaxel was performed. By means of a timely, guideline-conform therapy for tubal carcinoma, the neurological symptoms and, above all, the dysarthria could be improved after 10 months.

Entities:  

Keywords:  onconeuronal antibodies; paraneoplastic syndrome; tubal carcinoma

Year:  2014        PMID: 25364036      PMCID: PMC4210378          DOI: 10.1055/s-0034-1383041

Source DB:  PubMed          Journal:  Geburtshilfe Frauenheilkd        ISSN: 0016-5751            Impact factor:   2.915


  16 in total

1.  Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers.

Authors:  Bruno Giometto; Wolfgang Grisold; Roberta Vitaliani; Francesc Graus; Jérôme Honnorat; Guido Bertolini
Journal:  Arch Neurol       Date:  2010-03

Review 2.  Primary carcinoma of the fallopian tube. A report of 19 cases with literature review.

Authors:  C Schneider; E Wight; D Perucchini; U Haller; D Fink
Journal:  Eur J Gynaecol Oncol       Date:  2000       Impact factor: 0.196

3.  Autoimmune paraneoplastic cerebellar degeneration in ovarian carcinoma patients treated with plasmapheresis and immunoglobulin. A case report.

Authors:  Y B David; E Warner; M Levitan; D M Sutton; M G Malkin; J O Dalmau
Journal:  Cancer       Date:  1996-11-15       Impact factor: 6.860

4.  Recommended diagnostic criteria for paraneoplastic neurological syndromes.

Authors:  F Graus; J Y Delattre; J C Antoine; J Dalmau; B Giometto; W Grisold; J Honnorat; P Sillevis Smitt; Ch Vedeler; J J G M Verschuuren; A Vincent; R Voltz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

5.  Ovarian cancer and late onset paraneoplastic cerebellar degeneration.

Authors:  Bram H Goldstein; Connie L Birk; Mark Van Houten; Robert Veve; John V Brown; Mark A Rettenmaier; John P Micha
Journal:  Arch Gynecol Obstet       Date:  2008-11-06       Impact factor: 2.344

6.  Precursor lesions of high-grade serous ovarian carcinoma: morphological and molecular characteristics.

Authors:  Amy L Gross; Robert J Kurman; Russell Vang; Ie-Ming Shih; Kala Visvanathan
Journal:  J Oncol       Date:  2010-04-27       Impact factor: 4.375

7.  Paraneoplastic cerebellar degeneration in ovarian carcinoma: case report with review of immune modulation.

Authors:  W H Bradley; P R Dottino; J Rahaman
Journal:  Int J Gynecol Cancer       Date:  2008-01-22       Impact factor: 3.437

8.  Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.

Authors:  Setareh Shams'ili; Joost Grefkens; Bertie de Leeuw; Martin van den Bent; Herbert Hooijkaas; Bronno van der Holt; Charles Vecht; Peter Sillevis Smitt
Journal:  Brain       Date:  2003-06       Impact factor: 13.501

9.  Cerebellar degeneration and ocular myasthenia gravis in a patient with recurring ovarian carcinoma.

Authors:  Pietro Caliandro; Marco Luigetti; Enzo Ricci; Massimiliano Mirabella; Pietro Attilio Tonali; Luca Padua
Journal:  Neurol Sci       Date:  2009-10-06       Impact factor: 3.307

10.  Ovarian cancer: PCD and brain metastases.

Authors:  Vesna Stepanić; Visnja Matković; Ante Corusić; Dubravko Barisić; Damir Buković; Jadranka Ilić-Forko
Journal:  Coll Antropol       Date:  2007-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.